Evidence mapPaperPMID 32079705Full record

ReviewDiabetes2020

Understanding Metabolic Memory: A Tale of Two Studies.

Rachel G Miller, Trevor J Orchard

Open access · greenAbstract readReview
In one paragraph

Review in Diabetes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Update: the role of epigenetics in the metabolic memory of diabetic complications.American journal of physiology. Renal physiology · 2024
    Review
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rachel G MillerDepartment of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA millerr@edc.pitt.edu.ORCID 0000-0003-1845-8477
Trevor J OrchardDepartment of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
University of Pittsburgh · US

Funding

EPIDEMIOLOGY OF DIABETIC COMPLICATIONS--PHASE IIR01DK034818 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 1986 to 2005
$3.5M
NIDDK NIH HHS R01 DK034818
6 · The paper itself

Abstract

The results of the Diabetes Control and Complications Trial (DCCT) have given rise to much encouragement in the battle to stave off the complications of type 1 diabetes, showing dramatic declines in the development of severe retinopathy, nephropathy, and neuropathy in those treated intensively compared with conventional therapy. Particularly encouraging has been the continuing difference between the two groups despite both having similar HbA

Indexed as

Blood GlucoseCohort StudiesDiabetes ComplicationsDiabetes Mellitus, Type 1Diabetic NephropathiesDiabetic NeuropathiesDiabetic RetinopathyGlycated HemoglobinHumansHypoglycemic AgentsInsulinPatient Care PlanningProspective StudiesRandomized Controlled Trials as TopicTime FactorsBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulin

Identifiers

PMID32079705
PMCPMC7034186
OpenAlexW3007223980

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.